 | Up a level |
2014
Stilgenbauer, Stephan, Schnaiter, Andrea, Paschka, Peter, Zenz, Thorsten, Rossi, Marianna 
ORCID: 0000-0003-1661-1511, Doehner, Konstanze, Buehler, Andreas, Boettcher, Sebastian, Ritgen, Matthias, Kneba, Michael, Winkler, Dirk, Tausch, Eugen, Hoth, Patrick, Edelmann, Jennifer, Mertens, Daniel ORCID: 0000-0003-0227-7188, Bullinger, Lars, Bergmann, Manuela, Kless, Sabrina, Mack, Silja, Jaeger, Ulrich, Patten, Nancy, Wu, Lin, Wenger, Michael K., Fingerle-Rowson, Guenter, Lichter, Peter, Cazzola, Mario, Wendtner, Clemens M., Fink, Anna M., Fischer, Kirsten, Busch, Raymonde, Hallek, Michael and Doehner, Hartmut
(2014).
Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial.
Blood, 123 (21).
S. 3247 - 3255.
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 1528-0020
2012
Bloehdorn, Johannes, Sill, Martin, Buehler, Andreas, Mack, Silja, Winter, Doris, Bullinger, Lars, Rouhi, Arefeh, Kuchenbauer, Florian, Mertens, Daniel, Benner, Axel, Hallek, Michael, Doehner, Hartmut and Stilgenbauer, Stephan (2012). Microrna Expression in Fludarabine-Refractory CLL Implicates Independent Mechanisms of Resistance and Is Associated with Response and Progression Free Survival After Alemtuzumab Treatment: Results From the CLL2H Trial. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971
Schnaiter, Andrea, Rossi, Marianna, Paschka, Peter, Cazzola, Mario, Doehner, Konstanze, Edelmann, Jennifer, Buehler, Andreas, Kless, Sabrina, Mertens, Daniel, Busch, Raymonde, Mack, Silja, Hallek, Michael, Doehner, Hartmut and Stilgenbauer, Stephan (2012). NOTCH1, SF3B1 and TP53 Mutations in Fludarabine-Refractory CLL Patients Treated with Alemtuzumab: Results From the CLL2H Trial of the Gcllsg. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971
Stilgenbauer, Stephan, Busch, Raymonde, Schnaiter, Andrea, Paschka, Peter, Rossi, Marianna, Doehner, Konstanze, Zenz, Thorsten, Buehler, Andreas, Winkler, Dirk, Edelmann, Jennifer, Mertens, Daniel, Bullinger, Lars, Kless, Sabrina, Mack, Silja, Boettcher, Sebastian, Ritgen, Matthias, Kneba, Michael, Jaeger, Ulrich, Lichter, Peter, Patten, Nancy, Wenger, Michael K., Mendila, Myriam, Fingerle-Rowson, Gunter, Cazzola, Mario, Wendtner, Clemens, Fink, Anna Maria, Fischer, Kirsten, Hallek, Michael and Doehner, Hartmut (2012). Gene Mutations and Treatment Outcome in Chronic Lymphocytic Leukemia: Results From the CLL8 Trial. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971
Stilgenbauer, Stephan, Cymbalista, Florence, Leblond, Veronique, Delmer, Alain, Mack, Silja, Buehler, Andreas, Winkler, Dirk, Zenz, Thorsten, Busch, Raymonde, Ibach, Stefan, Choquet, Sylvain, Caroline, Dartigeas, Cazin, Bruno, Tournilhac, Olivier, Seiler, Till M., Zirlik, Katja, Alt, Juergen, Soekler, Martin, Schetelig, Johannes, Dreger, Peter, Hallek, Michael and Doehner, Hartmut (2012). Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971